医薬品添加剤の世界市場レポート 2024年

医薬品添加剤の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には6.6%の年間複合成長率（CAGR）で13兆3,997億7,000万米ドルに成長すると予想されます。今後の期間に予想される拡大は、政府の取り組み、革新的な医薬品の開発の促進、医療の高騰、高齢者人口の急速な増加に関連しており、これらすべてが市場の成長を促進します。予測期間に予測される主要な動向には、プラスチックの使用量を削減するための持続可能な包装の重視、市場での地位を強化するための合併と買収への集中、温室効果ガス排出量の最小化への注力、栄養素、水位、栄養物を監視するための人工知能の利用が含まれます。

ジェネリック医薬品の世界の売上高の増加は、医薬品添加剤市場の拡大において極めて重要な役割を果たしています。ジェネリック医薬品は、同じ剤形、安全性、強度、投与経路、品質を維持しながら、ブランド医薬品の代替品として機能します。India Brand Equity Foundation（IBEF）が指摘するように、インドは世界のジェネリック医薬品への最大の貢献国として際立っており、インドのジェネリック医薬品はこのカテゴリーにおける世界輸出総額の20％を占めています。特に、インドの製薬会社は米国でジェネリック医薬品の承認を300件獲得し、ジェネリック医薬品の需要の増加により医薬品添加剤市場をさらに刺激しました。

生物製剤の売上の急増により、医薬品の無菌検査市場が牽引されると予想されます。生物製剤には、生物由来の医薬品が含まれ、ワクチン、血液成分、アレルギー誘発物質、体細胞、遺伝子治療、組織、組換え治療用タンパク質などの幅広い製品が含まれます。生物製剤の文脈では、医薬品添加剤は安定性の向上、製剤の改良、活性生物学的薬剤の最適な送達の確保において重要な役割を果たします。たとえば、カナダ政府の報告によると、2023年にカナダでの生物製剤の売上高は110億米ドルを超え、生物製剤の売上増加による医薬品添加剤市場への重大な影響が浮き彫りになりました。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の医薬品添加剤市場の促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の医薬品添加剤の市場規模実績と成長、2018～2023年
• 世界の医薬品添加剤市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の医薬品添加剤市場、製品別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 無機化学薬品
• 有機化学品
• 世界の医薬品添加剤市場、製剤タイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 経口製剤
• 局所製剤
• 非経口製剤
• 世界の医薬品添加剤市場、機能別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 充填剤と希釈剤
• 懸濁剤と増粘剤
• コーティング剤
• バインダー
• 香料と甘味料
• 崩壊剤
• 着色剤
• 潤滑剤と流動促進剤
• その他

第7章 地域と国の分析

• 世界の医薬品添加剤市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界の医薬品添加剤市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 医薬品添加剤市場の競合情勢
• 医薬品添加剤市場の企業プロファイル
  • BASF SE
  • Ashland Global Holdings
  • Evonik Industries AG
  • International Flavors &Fragrances, Inc
  • Roquette Freres

第31章 その他の大手と革新的な企業

• Archer Daniels Midland Company
• Lubrizol Corporation
• Croda International Plc
• Kerry Group
• DuPont de Nemours, Inc.
• Sun Pharmaceuticals Industries Ltd
• Cipla Ltd
• Amster Microcell Private Limited
• Finar Limited
• PD Polychem Private Limited
• CAD Pharma Inc
• Maas Pharma Chemicals
• Aeon Procare Private Limited
• CSPC Pharmaceutical Group Ltd
• Allen &Hanburys Ltd

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

Pharmaceutical excipients are non-active pharmaceutical ingredients (API) that form part of a drug delivery system and have undergone rigorous safety evaluations. While not possessing inherent activity, these excipients play a crucial role in facilitating the administration of the drug in the correct form and supporting its mode and site of action.

Pharmaceutical excipients come in various types, with the primary categories being inorganic chemicals, organic chemicals, and others. The pharmaceutical inorganic chemical sector focuses on the manufacturing, physical or chemical characteristics, assay techniques, and applications of inorganic substances used as pharmaceutical aids, treatments, and diagnostics. These excipients serve different functionalities, including but not limited to fillers and diluents, suspending and viscosity agents, coating agents, flavoring agents, sweeteners, disintegrants, colorants, lubricants, glidants, and others. Additionally, they are utilized in diverse formulations such as oral, topical, and parental formulations.

The pharmaceutical excipients market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical excipients market statistics, including pharmaceutical excipients industry global market size, regional shares, competitors with a pharmaceutical excipients market share, detailed pharmaceutical excipients market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical excipients industry. This pharmaceutical excipient market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical excipients market size has grown strongly in recent years. It will grow from $9728.83 billion in 2023 to $10378.8 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The expansion observed in the past period can be ascribed to robust economic development in emerging markets, an upswing in the market for generic drugs, and the increasing establishment of advanced healthcare infrastructure.

The pharmaceutical excipients market size is expected to see strong growth in the next few years. It will grow to $13399.77 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The anticipated expansion in the upcoming period is linked to government initiatives, a heightened development of innovative drugs, escalating healthcare expenditure, and a swift rise in the elderly population, all of which will propel market growth. Key trends projected for the forecast period involve an emphasis on sustainable packaging to diminish plastic usage, concentration on mergers and acquisitions to fortify market standing, a focus on minimizing greenhouse gas emissions, and the utilization of artificial intelligence to monitor nutrients, water levels, and enhance transparency in supply chains.

The global upswing in generic drug sales has played a pivotal role in the expansion of the pharmaceutical excipients market. Generic drugs serve as alternatives to branded medications, maintaining the same dosage form, safety, strength, route of administration, and quality. India, as noted by the India Brand Equity Foundation (IBEF), stands out as the largest contributor to generic medicines globally, with its generic drugs constituting 20% of the total global exports in this category. Notably, Indian pharmaceutical companies secured 300 approvals for generic drugs in the USA, further fueling the pharmaceutical excipients market due to increased demand for generic drugs.

The upsurge in the sales of biologics is anticipated to drive the pharmaceutical sterility testing market. Biologics encompass medicines derived from living organisms, encompassing a range of products such as vaccines, blood components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. In the context of biologics, pharmaceutical excipients play a crucial role in enhancing stability, refining formulation, and ensuring the optimal delivery of active biological agents. For instance, in 2023, as reported by the Government of Canada, biologics sales surpassed $11 billion in Canada, highlighting the significant impact on the pharmaceutical excipients market attributed to the increased sales of biologics.

The growing emphasis on research and development in pharmaceutical formulation, aimed at improving production processes and product quality through the utilization of multi-functional excipients, is a notable trend influencing the market. Excipients play a crucial role in enabling pharmaceutical manufacturers to better support patients by enhancing compliance and treatment effectiveness. An illustrative example is Evonik's recent introduction of EUDRAGIT FS 100, a solid iteration of the existing EUDRAGIT FS 30 D. This innovative multi-functional version opens up new possibilities for pharmaceutical companies, allowing the polymer to be used in various applications such as hot-melt extrusion, solvent spray-drying, and solvent coating. Such applications were previously unattainable when only the aqueous version was available.

Key players in the pharmaceutical excipient market are introducing advanced excipients such as Apisolex to streamline manufacturing processes and minimize losses of active pharmaceutical ingredients (APIs). Apisolex, an innovative solubility-enhancing excipient technology, addresses and overcomes solubility challenges. In a notable example from March 2022, Lubrizol Life Science (LLS) Health, a pharmaceutical contract development and drug product manufacturing organization based in the US, launched Apisolex to enhance solubility and simplify the manufacturing of parenteral drug products. This excipient can significantly increase solubility, support high drug loading, and optimize manufacturing by reducing API loss and ensuring efficient encapsulation.

In July 2021, Philip Morris International, a US-based cigarette and tobacco manufacturing company, acquired Fertin Pharma for $820 million. This acquisition positions PMI to enhance its capabilities in developing, formulating, and marketing both existing and new smoke-free platforms. Fertin Pharma, based in Denmark, specializes in the manufacture of pharmaceutical excipients.

Major companies operating in the pharmaceutical excipients market report are BASF SE, Ashland Global Holdings, Evonik Industries AG, International Flavors & Fragrances, Inc., Roquette Freres, Archer Daniels Midland Company, Lubrizol Corporation, Croda International PLC, Kerry Group, DuPont de Nemours, Inc., Sun Pharmaceuticals Industries Ltd., Cipla Ltd., Amster Microcell Private Limited, Finar Limited, P. D. Polychem Private Limited, CAD Pharma Inc., Maas Pharma Chemicals, Aeon Procare Private Limited, CSPC Pharmaceutical Group Ltd., Allen & Hanburys Ltd., Actelion Pharmaceuticals UK Ltd., Colorcon, MEGGLE GmbH & Co. KG, Boehringer Ingelheim International GmbH, Alexion Pharma, DMV-Fonterra Excipients GmbH & Co. KG, Alpen Pharma AG, Avantor Inc., JRS PHARMA GmbH & Co. KG, The Dow Chemical Co, Pfizer, AbbVie Inc., EMS Pharma, Biolab Farmaceutica, Medist FZE, W.R. Grace, Univar Solutions, Nitika Pharma, DFE Pharma, Cargill, Sensient Pharma.

North America is the largest region in the pharmaceutical excipients market in 2023. Middle East is expected to be the fastest growing region in the global pharmaceutical excipients market share during the forecast period. The regions covered in the pharmaceutical excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pharmaceutical excipients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The pharmaceutical excipients market consists of sales of microcrystalline cellulose, stearic acid, gelatin, and tartaric acid. Values in this market are 'factory gate values,' that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Excipients Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical excipients market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical excipients? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical excipients market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Inorganic Chemicals; Organic Chemicals; Other Products
• 2) By Functionality: Fillers And Diluents; Suspending And Viscosity Agents; Coating Agents; Binders; Flavoring Agents And Sweeteners; Disintegrants; Colorants; Lubricants And Glidants; Other Functionalities
• 3) By Type Of Formulation: Oral Formulation; Topical Formulation; Parenteral Formulation; Other Formulations
• Companies Mentioned: BASF SE; Ashland Global Holdings; Evonik Industries AG; International Flavors & Fragrances, Inc; Roquette Freres
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Excipients Market Characteristics

3. Pharmaceutical Excipients Market Trends And Strategies

4. Pharmaceutical Excipients Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Pharmaceutical Excipients Market Size and Growth

• 5.1. Global Pharmaceutical Excipients Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Pharmaceutical Excipients Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Pharmaceutical Excipients Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pharmaceutical Excipients Market Segmentation

• 6.1. Global Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Inorganic Chemicals
• Organic Chemicals
• 6.2. Global Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral Formulation
• Topical Formulation
• Parental Formulation
• 6.3. Global Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Fillers And Diluents
• Suspending And Viscosity Agents
• Coating Agents
• Binders
• Flavoring Agents And Sweeteners
• Disintegrants
• Colorants
• Lubricants And Glidants
• Other Functionalities

7. Pharmaceutical Excipients Market Regional And Country Analysis

• 7.1. Global Pharmaceutical Excipients Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Pharmaceutical Excipients Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pharmaceutical Excipients Market

• 8.1. Asia-Pacific Pharmaceutical Excipients Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pharmaceutical Excipients Market

• 9.1. China Pharmaceutical Excipients Market Overview
• 9.2. China Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pharmaceutical Excipients Market

• 10.1. India Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pharmaceutical Excipients Market

• 11.1. Japan Pharmaceutical Excipients Market Overview
• 11.2. Japan Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pharmaceutical Excipients Market

• 12.1. Australia Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pharmaceutical Excipients Market

• 13.1. Indonesia Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pharmaceutical Excipients Market

• 14.1. South Korea Pharmaceutical Excipients Market Overview
• 14.2. South Korea Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pharmaceutical Excipients Market

• 15.1. Western Europe Pharmaceutical Excipients Market Overview
• 15.2. Western Europe Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pharmaceutical Excipients Market

• 16.1. UK Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pharmaceutical Excipients Market

• 17.1. Germany Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pharmaceutical Excipients Market

• 18.1. France Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pharmaceutical Excipients Market

• 19.1. Italy Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pharmaceutical Excipients Market

• 20.1. Spain Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pharmaceutical Excipients Market

• 21.1. Eastern Europe Pharmaceutical Excipients Market Overview
• 21.2. Eastern Europe Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pharmaceutical Excipients Market

• 22.1. Russia Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pharmaceutical Excipients Market

• 23.1. North America Pharmaceutical Excipients Market Overview
• 23.2. North America Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pharmaceutical Excipients Market

• 24.1. USA Pharmaceutical Excipients Market Overview
• 24.2. USA Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pharmaceutical Excipients Market

• 25.1. Canada Pharmaceutical Excipients Market Overview
• 25.2. Canada Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pharmaceutical Excipients Market

• 26.1. South America Pharmaceutical Excipients Market Overview
• 26.2. South America Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pharmaceutical Excipients Market

• 27.1. Brazil Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pharmaceutical Excipients Market

• 28.1. Middle East Pharmaceutical Excipients Market Overview
• 28.2. Middle East Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pharmaceutical Excipients Market

• 29.1. Africa Pharmaceutical Excipients Market Overview
• 29.2. Africa Pharmaceutical Excipients Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Pharmaceutical Excipients Market, Segmentation By Type Of Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pharmaceutical Excipients Market Competitive Landscape And Company Profiles

• 30.1. Pharmaceutical Excipients Market Competitive Landscape
• 30.2. Pharmaceutical Excipients Market Company Profiles
  • 30.2.1. BASF SE
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Ashland Global Holdings
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Evonik Industries AG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. International Flavors & Fragrances, Inc
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Roquette Freres
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Pharmaceutical Excipients Market Other Major And Innovative Companies

• 31.1. Archer Daniels Midland Company
• 31.2. Lubrizol Corporation
• 31.3. Croda International Plc
• 31.4. Kerry Group
• 31.5. DuPont de Nemours, Inc.
• 31.6. Sun Pharmaceuticals Industries Ltd
• 31.7. Cipla Ltd
• 31.8. Amster Microcell Private Limited
• 31.9. Finar Limited
• 31.10. P. D. Polychem Private Limited
• 31.11. CAD Pharma Inc
• 31.12. Maas Pharma Chemicals
• 31.13. Aeon Procare Private Limited
• 31.14. CSPC Pharmaceutical Group Ltd
• 31.15. Allen & Hanburys Ltd

32. Global Pharmaceutical Excipients Market Competitive Benchmarking

33. Global Pharmaceutical Excipients Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pharmaceutical Excipients Market

35. Pharmaceutical Excipients Market Future Outlook and Potential Analysis

• 35.1 Pharmaceutical Excipients Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Pharmaceutical Excipients Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Pharmaceutical Excipients Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer